MSLN and pancreatic ductal adenocarcinoma: We next utilized a non-immortalized pancreatic ductal adenocarcinoma patient-derived xenograft (PDX) cell line (PDX1294), which has high expression levels of both Tn antigen and mesothelin (Fig. 4h–j and Supplementary Fig. 4e).